Log In
BCIQ
Print this Print this
 

VTI-1001

  Manage Alerts
Collapse Summary General Information
Company viDA Therapeutics Inc.
DescriptionUndisclosed granzyme B (GrB; GZMB) inhibitor
Molecular Target Granzyme B (GrB) (GZMB)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationLupus
Indication DetailsTreat discoid lupus erythematosus (DLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today